Proteins and Peptides
30 June 2017
Cytovation Announces Private Fundraising Round of NOK 20m to Progress CyPep-1 to Phase 1 Clinical Study27 June 2017
Ra Pharmaceuticals Announces Initial Data from Phase 2 Clinical Trial of RA101495 in PNH25 June 2017
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial22 June 2017
Phase 2a trial results support development of dasiglucagon in the iLet pump system for type 1 diabetes19 June 2017
Glepaglutide meets primary endpoint in Phase 2 trial in patients with short bowel syndrome15 June 2017
Catalyst Biosciences and ISU Abxis Complete Dosing of First Patient Cohort in Hemophilia B Clinical Trial13 June 2017
Novelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes Association12 June 2017
Zealand to regain control of elsiglutideNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports